Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $25.01 million. The enterprise value is $28.98 million.
Market Cap | 25.01M |
Enterprise Value | 28.98M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SER has 2.50 million shares outstanding.
Shares Outstanding | 2.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.03% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 176.11 |
Forward PS | n/a |
PB Ratio | 4.57 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 204.07 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13, with a Debt / Equity ratio of 0.80.
Current Ratio | 0.13 |
Quick Ratio | 0.08 |
Debt / Equity | 0.80 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.02 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -120.90% |
Return on Capital (ROIC) | -100.43% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.25% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -57.25% |
50-Day Moving Average | 13.01 |
200-Day Moving Average | 18.97 |
Relative Strength Index (RSI) | 40.36 |
Average Volume (30 Days) | 5,209 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SER had revenue of $142,000 and -$14.80 million in losses. Loss per share was -$13.72.
Revenue | 142,000 |
Gross Profit | 102,000 |
Operating Income | -9.88M |
Pretax Income | -14.80M |
Net Income | -14.80M |
EBITDA | -9.77M |
EBIT | -9.90M |
Loss Per Share | -$13.72 |
Balance Sheet
The company has $395,000 in cash and $4.37 million in debt, giving a net cash position of -$3.97 million or -$1.59 per share.
Cash & Cash Equivalents | 395,000 |
Total Debt | 4.37M |
Net Cash | -3.97M |
Net Cash Per Share | -$1.59 |
Equity / Book Value | 5.47M |
Book Value Per Share | 2.19 |
Working Capital | -5.16M |
Cash Flow
Operating Cash Flow | -7.80M |
Capital Expenditures | n/a |
Free Cash Flow | -7.80M |
FCF Per Share | -$7.23 |
Margins
Gross margin is 71.83%, with operating and profit margins of -6,954.93% and -10,424.65%.
Gross Margin | 71.83% |
Operating Margin | -6,954.93% |
Pretax Margin | -10,424.65% |
Profit Margin | -10,424.65% |
EBITDA Margin | -6,881.69% |
EBIT Margin | -6,973.94% |
FCF Margin | -5,492.96% |
Dividends & Yields
SER does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -59.19% |
FCF Yield | -31.19% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SER has an Altman Z-Score of -16.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.3 |
Piotroski F-Score | 3 |